Planned website maintenance is taking place from 11:00 pm AEDT on Friday 30 October to 6:00 am AEDT on Saturday 31 October 2026. Some pages may be temporarily unavailable. If issues continue outside this time, please contact us.
Sponsor content
359 result(s) found, displaying 171 to 180
-
Designation or determinationProvisional approval
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PREVYMIS letermovir 240 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PREVYMIS letermovir 240 mg/12 mL concentrated injection for infusion vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PREVYMIS letermovir 480 mg/24 mL concentrated injection for infusion vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PREVYMIS letermovir 480 mg film-coated tablet blister pack.
-
Cancellation by sponsorRequested by Merck Sharp & Dohme (Australia) Pty Ltd
-
Cancellation by sponsorRequested by Merck Sharp & Dohme (Australia) Pty Ltd
-
Cancellation by sponsorRequested by Merck Sharp & Dohme (Australia) Pty Ltd
-
Designation or determinationPriority review
-
Designation or determinationOrphan drug